Cost-effectiveness analyses and their role in improving healthcare strategies

Current Opinion in Obstetrics and Gynecology

Volumn 25, Issue 6, 2013, Pages 487-493

  Rodriguez, Maria I ^a   Caughey, Aaron B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cost effectiveness analysis; costbenefit analysis; decision analysis

Indexed keywords

CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EVIDENCE BASED PRACTICE; GYNECOLOGIST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; OBSTETRICIAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; UNITED STATES;

COST-BENEFIT ANALYSIS; DECISION MAKING; DELIVERY OF HEALTH CARE; FEMALE; GYNECOLOGY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MODELS, ECONOMETRIC; OBSTETRICS; POLICY MAKING; PREGNANCY; QUALITY IMPROVEMENT; UNITED STATES;

EID: 84888135049     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0000000000000020     Document Type: Review

References (47)

1. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood) 2008; 27:759-769.
2. Chernew ME, Hirth RA, Cutler DM. Increased spending on healthcare: how much can the United States afford? Health Aff (Millwood) 2003; 22:15-25.
3. Heffler S, Smith S, Won G, et al. Health spending projections for 2001-2011: the latest outlook. Health Aff (Millwood) 2002; 21:207-218.
4. Hill SR. Cost-effectiveness analysis for clinicians. BMC Med 2012; 10:10.
5. Burlone S, Edelman AB, Caughey AB, et al. Extending contraceptive coverage under the Affordable Care Act saves public funds. Contraception 2012; 87:143-148.
6. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990; 113:147-154.
7. Detsky AS, Laupacis A. Relevance of cost-effectiveness analysis to clinicians and policy makers. JAMA 2007; 298:221-224.
8. Eisenberg JM, Clinical economics. A guide to the economic analysis of clinical practices. JAMA 1989; 262:2879-2886.
9. Grosse SD, Teutsch SM, Haddix AC. Lessons from cost-effectiveness research for United States public health policy. Annu Rev Public Health 2007; 28:365-391.
10. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296:716-721.
11. Bosmans JE, de Bruijne MC, van Hout HP, et al. Practical guidelines for economic evaluations alongside equivalence trials. Value Health 2008; 11:251-258.
12. Caughey AB, Kaimal AJ, Odibo AO. Cost-effectiveness of Down syndrome screening paradigms. Clin Lab Med 2010; 30:629-642.
13. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5:1-30.
14. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of healthcare programs. Health Serv Res 1972; 7:118-133.
15. Detsky AS, Naglie G, Krahn MD, et al. Primer on medical decision analysis. Part 2. Building a tree. Med Decis Making 1997; 17:126-135.
16. Detsky AS, Naglie G, Krahn MD, et al. Primer on medical decision analysis. Part 1. Getting started. Med Decis Making 1997; 17:123-125.
17. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276:1253-1258.
18. Subak LL, Caughey AB, Washington AE. Cost-effectiveness analyses in obstetrics & gynecology. Evaluation of methodologic quality and trends. J Reprod Med 2002; 47:631-639.
19. Vintzileos AM, Beazoglou T. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics. Am J Obstet Gynecol 2004; 191:1070-1076.
20. Rodriguez MI, Caughey AB, Edelman A, et al. Cost-benefit analysis of stateand hospital-funded postpartum intrauterine contraception at a university hospital for recent immigrants to the United States. Contraception 2010; 81:304-308.
21. Rodriguez MI, Jensen JT, Darney PD, et al. The financial effects of expanding postpartum contraception for new immigrants. Obstet Gynecol 2010; 115:552-558.
22. Trussell J, Koenig J, Ellertson C, Stewart F. Preventing unintended pregnancy: the cost-effectiveness of three methods of emergency contraception. Am J Public Health 1997; 87:932-937.
23. Trussell J, Lalla AM, Doan QV, et al. Cost effectiveness of contraceptives in the United States. Contraception 2009; 79:5-14.
24. Trussell J, Shochet T. Cost-effectiveness of emergency contraceptive pills in the public sector in the USA. Expert Rev Pharmacoecon Outcomes Res 2003; 3:433-440.
25. Trussell J. Update on the cost-effectiveness of contraceptives in the United States. Contraception 2010; 82:391.
26. Amaral G, Foster DG, Biggs MA, et al. Public savings from the prevention of unintended pregnancy: a cost analysis of family planning services in California. Health Serv Res 2007; 42:1960-1980.
27. Foster DG, Biggs MA, Amaral G, et al. Estimates of pregnancies averted through California's family planning waiver program in 2002. Perspect Sex Reprod Health 2006; 38:126-131.
28. Foster DG, Biggs MA, Rostovtseva D, et al. Estimating the fertility effect of expansions of publicly funded family planning services in California. Womens Health Issues 2011; 21:418-424.
29. Foster DG, Klaisle CM, Blum M, et al. Expanded state-funded family planning services: estimating pregnancies averted by the Family PACT Program in California 1997-1998. Am J Public Health 2004; 94:1341-1346.
30. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2011; 12:19-26.
31. Baeten JM, Benki S, Chohan V, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007; 21:1771-1777.
32. Morrison CS, Chen PL, Kwok C, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2012; 24:1778-1781.
33. Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS 2011; 26:375-380.
34. Morrison CS, Skoler-Karpoff S, Kwok C, et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS 2011; 26:497-504.
35. Reid SE, Dai JY, Wang J, et al. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr 2009; 53:606-613.
36. Kleinschmidt I, Rees H, Delany S, et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007; 75:461-467.
37. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007; 36:166-174.
38. Kiddugavu M, Makumbi F, Wawer MJ, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003; 17:233-240.
39. Jain AK. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies. Contraception 2012; 86:645-652.
40. Rodriguez MI, Reeves MF, Caughey AB. Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis. BJOG 2012; 119:1067-1073.
41. Butler AR, Smith JA, Polis CB, et al. Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS 2012; 27:105-113.
42. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005; 353:2158-2168.
43. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ 2001; 79:954-962.
44. Denny L, Kuhn L, Pollack A, et al. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000; 89:826-833.
45. Kuhn L, Denny L, Pollack A, et al. Human papillomavirusDNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000; 92:818-825.
46. Sankaranarayanan R, Shyamalakumary B, Wesley R, et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer 1999; 80:161-163.
47. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a clusterrandomised trial. Lancet 2007; 370:398-406.